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Syncope after myocardial infarction. Changes of the results of pro-
grammed ventricular stimulation during the last 26 years
Béatrice Brembilla-Perrot, Bérivan Azman, Nicolas Sadoul, Hugues
Blangy, Olivier Claudon, Karim Djaballah, Pierre Louis, Olivier Selton,
Lucian Muresan, Sonia Magalhes, Pierre Yves Zinzius, Arnaud Terrier De
La Chaise
CHU of Brabois, Cardiologie, Vandoeuvre Les Nancy, France
Ventricular tachycardia (VT) may explain syncope after myocardial infarc-
tion (MI) and is in this case is associated with a high risk of sudden death,
mainly in association with low left ventricular ejection fraction (LVEF). Pro-
grammed ventricular stimulation (PVS) remains the main method to look for
VT. The purpose of the study was to look for the changes of the population
referred for PVS for unexplained syncope after MI during the last 26 years.
Methods: 346 patients were recruited for unexplained syncope after MI
between 1982 and 2008: 76 patients (group I) were studied between 1982 and
1989; 151 patients (group II) were studied between 1990 and 1999 and 119
patients (group III) were studied between 2000 and 2008. ECG and 24 hour
Holter monitoring did not indicate a possible cause of syncope. LVEF was
evaluated in all patients by echocardiography. PVS was systematic with the
same protocol (up to 3 extrastimuli in 2 sites of right ventricle).
Results: Clinical and electrophysiological data were similar between
groups I and II but differed significantly in group III: age was higher in group
III (68±12 years) than in group I (64±11) and II (65±12) (p <0.009); LVEF
was higher in group III (45±13%) than in group I (41±16) and II (42±13)
(p<0.008). PVS was more frequently negative in group III (74%) than in group
I (43%) and II (54 %) (p<0.001). Monomorphic VT < 270 b/min was less fre-
quently induced in group III (16 %) than in group I (30 %) and II (26 %)
(p<0.01). Ventricular flutter (VT > 270/min) and ventricular fibrillation were
less frequently induced in group III (9 %) than in group I (26 %) and II (19
%) (p<0.05).The changes could be related to the ICD implantation recommen-
dations and to recanalization of occluded coronary artery, which is systematic
in recent MI since 2000 (38 % in group III, 27 % in groups I and II) (p <0.05).
Conclusions: Clinical data and results of PVS in patients admitted for
unexplained syncope after MI infarction were identical between 1982 and 199
and have changed since 2000; patients are older and had relatively preserved
LVEF. Therefore, the induction of a ventricular tachyarrhythmia is rarer than
before the year 2000.
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Objective: To compare the effect of two Proton Pomp Inhibitors (PPI) on
platelet response to clopidogrel after coronary stenting for Non ST Elevation
Acute Coronary Syndrome (NSTE ACS).
Background: Use of omeprazole has been reported to decrease signifi-
cantly the clopidogrel antiplatelet effect because of cytochrome P450 interac-
tion. As all PPIs are metabolized by CYP2C19, but to a varying degree, we
hypothesized that the reported negative omeprazole-clopidogrel drug interac-
tion may not be due to a class effect.
Methods and Results: 104 patients undergoing coronary stenting for
NSTE ACS were prospectively included and randomized to omeprazole or
pantoprazole 20 mg. They received at discharge 75 mg aspirin and 150 mg
clopidogrel. Platelet reactivity index VASP was used to assess clopidogrel res-
ponse and ADP-induced aggregation for platelet reactivity (ADP-Ag). After
one month, patients receiving pantoprazole had a significantly better platelet
response to clopidogrel as assessed with the PRI VASP: 36±20 % vs 48±17 %,
p=0.007. We identified more clopidogrel non responders in the omeprazole
group than in the pantoprazole group: 44% vs 23%, p=0.04, OR 2.6 [1.2-6.2].
Conversely, we did not observe any significant difference in platelet reactivity
with ADP-Ag between omeprazole and pantoprazole groups: 52±15 % and
50±18 % respectively, p=0.29.
Conclusion: The present findings suggest the preferential use of pantopra-
zole compared to omeprazole in patients receiving clopidogrel to avoid any
potential negative interaction with CYP2C19.
036
Comparison of the Angiographic Myocardial Blush Grade with
Delayed Enhanced Cardiac Magnetic Resonance for the assessment of
Microvascular Obstruction in Acute Myocardial Infarctions
Jacques Vicente, Nathan Mewton, Pierre Croisille, Patrick Staat, Eric
Bonnefoy, Michel Ovize, Didier Revel
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Background: Myocardial Blush Grade (MBG) and cardiac magnetic reso-
nance (CMR) are both imaging tools that can assess myocardial reperfusion
after primary percutaneous coronary intervention (PCI) for acute myocardial
infarction (AMI).
Objectives: We studied the relation between MBG and gadolinium-
enhanced CMR for the assessment of microvascular obstruction (MVO) in
patients with acute ST-elevated myocardial infarction (STEMI) treated by pri-
mary PCI.
Material and Methods: MBG was assessed in 39 patients with initial
TIMI 0 STEMI successfully treated by PCI, resulting in TIMI 3 flow grade
and complete ST-segment resolution. These MBG values were related to
MVO determined by CMR, performed between 2 and 7 days after PCI. Left
ventricular (LV) volumes were determined at baseline, and at 6-month follow
up.
Results: No statistical relation was found between MBG and MVO extent
at CMR (p=0.63). Regarding MBG 0 and 1 as a sign of MVO, the sensitivity
and specificity of these scores were respectively 53.8% and 75%. In this study,
CMR determined MVO was the only significant LV remodeling predicting
factor (_=31.8; p=0.002), whatever the MBG status was.
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